LEU— AI Stock Forecast & Price Targets
Published 8/5/2026 · A free sample of K3vl4r’s AI-powered analysis.
Kronos price forecasts, scored fundamentals & technicals, and a multi-horizon plan.
View the live LEU price forecast →
Centrus Energy retains a genuine structural moat as the sole U.S.-licensed HALEU enricher with $1.87B cash and a $3.9B+ backlog, but at $189.24 trades at ~41x forward P/E, ~74x EV/EBITDA, and ~8.2x sales against a negative TTM operating margin and accelerating FCF burn (-$58M in Q1). With Q2 earnings tonight (Aug 5 AMC), 26.4% short float, and price already +16% in a week into resistance, the setup is binary and asymmetrically risky for new buyers — hold existing, do not chase.
Earnings stance: DO NOT initiate or add ahead of Aug 5 AMC. The setup is asymmetrically bad for new buyers — +16% one-week rally into the print, price pinned at $190 resistance, JPM cut to $178, 26.4% short float that could either fuel a squeeze on any beat or accelerate the flush on a miss. If holding, consider trimming 20-30% into the print to lock in the bounce. Post-print plan: (1) beat + gross margin >35% + reaffirmed FY guide = look to add on any pullback to $185-190 with stops below $170; (2) in-line/miss or margin regression below 30% = expect gap to $165-170 zone, potentially $150s. Invalidation for any bullish tactical view: daily close below $170.
1-6 month view: HOLD with a base case that the stock chops in a $150-$210 range as it digests capex burn and awaits margin proof points. The Q1'26 41% gross margin is the swing variable — if Q2 confirms ≥35% and management reaffirms FY26 revenue and Piketon pacing without a capital raise announcement, base case shifts toward $210-$220. If margin reverts toward the mid-20s and FCF burn accelerates, downside to $140-$150 is realistic given the -22% YTD performance and JPM's $178 target. Expected return range: -20% to +15% over 6 months, skewed negative on valuation. What changes my mind: (a) a signed additional multi-year HALEU offtake at premium pricing, or (b) two consecutive quarters of >35% gross margin.
1-3 year terminal thesis: Centrus is the option on U.S. HALEU independence, and if Piketon scales to commercial production the current market cap could look cheap versus a $3.9B backlog through 2040 and structural monopoly economics. Multi-year drivers: SMR deployment cycles, DOE contract expansion, HALEU supply-demand imbalance post-Russia sanctions, and potential DOD/nuclear defense adjacencies. Biggest structural risk: execution and dilution — Piketon requires substantial ongoing capex that current operating cash flow does not support, meaning a 2027-2028 equity raise is plausible; competing enrichment capacity from Urenco or a restart of overseas Russian supply could compress the moat's economic value even if the license monopoly persists. Fair value 2-3 years out assuming margin normalization to 30% and revenue scaling to $700M: $200-$280; bull case with successful Piketon ramp: $350+.
Revenue is choppy and seasonal: Q1'26 $76.7M (vs Q4'25 $146.2M, Q3'25 $74.9M, Q2'25 $154.5M), producing a lumpy TTM of $452.3M and Sales Y/Y TTM of -4.05%. The bright spot is Q1'26 gross margin of 41.1% versus a deeply negative Q3'25 (-5.7%) and 34.9% in Q2'25 — repeatability of this gross margin is the single most important variable for the thesis. Operating margin is still -0.26% on a TTM basis, and free cash flow has swung sharply negative (Q1'26 -$58.3M, Q4'25 -$58M) as Piketon capex ramps (Q1 capex $23.2M vs $3.6M a year earlier). The balance sheet is the real cushion: $1.87B cash, working capital $1.89B, current ratio 5.72, and stockholders' equity that jumped from $359M in Q2'25 to $775M in Q1'26 — implying a capital raise or convertible activity that has already diluted holders and pre-funded capex. Total debt of $1.18B with debt/equity 1.52 is manageable given the cash pile (net cash position). Trailing P/E 62.7, forward P/E 41 (Finviz shows 69.2), P/S 8.2, EV/EBITDA 73.8 — these are venture-like multiples on a business with -$59M quarterly FCF. Quality is strong on liquidity and backlog, broken on cash conversion and margin consistency.
Across timeframes the trend is bifurcated. The 1-week chart shows LEU is well off the Jan peak near $380 with a 52-week range of $142–$464 (-59% from high, +33% from low). The daily chart shows a decisive V-reversal from the mid-July low (~$147) to $189.83, +28% in three weeks, and price has now reclaimed the March-May trading range. On the 4h chart, price is testing the underside of the prior $190–$230 congestion zone — a critical resistance shelf. The 1h chart shows the vertical push from Aug 3 stalling right at $190, with the model projecting a pullback to ~$179 near-term. RSI 59.7 (not yet overbought), price is +12.8% above SMA20 and +10.8% above SMA50 but still -16.9% below SMA200 — classic mean-reversion bounce inside a broader downtrend. The model's 1d bullish_prob of 1.0 but realized directional accuracy (64%) trails the naive baseline (68%), and the 1wk model is unreliable; upside forecast bands on the 4h/1d ($206–$230) should be heavily discounted. Key support: $170 (breakout level), then $160, then $147. Key resistance: $195, $210, $230.
The dominant near-term catalyst is Q2 earnings Aug 5 AMC. Sell-side has turned more cautious into the print: JP Morgan (Jul 29) reiterated Neutral and cut PT from $236 to $178 — below current price — while Zacks flags an expected YoY earnings and revenue decline with an unfavorable Earnings ESP. Truist initiated Buy (Jul 15) and picked LEU over OKLO as its top nuclear name, providing counterweight. Multiple valuation commentary pieces (Simply Wall St, Jul 30-31) explicitly call the stock 'fully priced' after the 7x 5-year run and highlight that EPS estimate cuts are pressuring the growth narrative. Signal: consensus recom 1.67 (buy-tilt) and average PT $256 remain above spot, but the freshest revision (JPM to $178) is more informative than stale bullish PTs. The 3.3pp jump in short float to 26.4% over 45 days combined with a 6.8pp rise in institutional ownership is a classic pre-catalyst tug-of-war — informed sellers and index/quant buyers on both sides of the print. Retail sentiment is uniformly bullish, which in this name has been a contrarian tell.
- $3.9B+ contracted backlog through 2040 provides multi-year revenue visibility tied to SMR deployment
- Sole U.S.-licensed HALEU enricher under active DOE contracts ($1.07B DOE contract + $900M Piketon task order)
- Q1'26 gross margin spike to 41.1% (from -5.7% in Q3'25) suggests operating leverage potential if repeatable
- $1.87B cash cushion (~$95/share, ~50% of market cap) pre-funds Piketon capex ramp without immediate dilution
- Institutional ownership rose 6.8pp to 78.4% over 45 days — real-money accumulation despite valuation concerns
- Truist initiated Buy naming LEU top nuclear pick over OKLO, signaling incremental sell-side conviction on structural story
- Extreme valuation: 41x forward P/E, 74x EV/EBITDA, 8.2x sales on a business with -0.26% TTM operating margin — no cushion for any miss
- Q2 earnings Aug 5 AMC is binary; JPM just cut PT to $178 (below spot) and Zacks flags negative Earnings ESP
- FCF burn accelerating: -$58M Q1'26 and -$58M Q4'25, with capex up 6x YoY as Piketon ramps — future dilution highly plausible
- Short float 26.4% (up 3.3pp in 45d) signals informed positioning against the rally and cuts both ways into the print
- Q1'26 revenue only $76.7M vs $146M in Q4'25 — quarterly revenue is extremely lumpy, making single-quarter margin prints unreliable
- Down 59% from 52-week high of $464 and -22% YTD despite the recent bounce — the primary trend is still corrective
- Retail sentiment 100% bullish into a binary event has historically been a contrarian warning in this name
- Forecast model directional accuracy (64%) trails naive baseline (68%) — the projected upside bands should not be relied upon
Get AI analysis on any stock
This is one of hundreds of Kronos AI reports — scored fundamentals & technicals, bull/base/bear price targets, a multi-horizon plan, and continuously-updated forecasts across the market. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord